Artificial Intelligence in Breast Cancer Screening Programs in C rdoba (AITIC)

  • End date
    Jun 10, 2023
  • participants needed
  • sponsor
    Maimónides Biomedical Research Institute of Córdoba
Updated on 10 July 2021


The use of artificial intelligence software in breast screening (Transpara) makes it possible to identify studies with a very low probability of cancer.

The hypothesis raised in this work is that reading strategies based on artificial intelligence (single or double reading only of cases with a score> 7 with Transpara), allow reducing the workload of a screening program by more than 50 % with respect to the standard reading of the program (double reading of all cases without Transpara), without presenting inferiority in terms of detection rates and recalls of the program, both with the use of 2D digital mammography and with the use of tomosynthesis or 3D mammogram.

Condition Breast Cancer Diagnosis, Breast Cancer, breast carcinoma, cancer, breast
Treatment Mammograms, Mammograms
Clinical Study IdentifierNCT04949776
SponsorMaimónides Biomedical Research Institute of Córdoba
Last Modified on10 July 2021


Yes No Not Sure

Inclusion Criteria

Any woman between the ages of 50 and 69, from the hospital area of the Reina Sofa University Hospital, invited to the Breast Cancer Early Detection Program, summoned in rooms 2024 and 2001 and who agrees to participate in the study by signing the consent informed
Women studied in the program in the set period and who have previously participated
Women who are studied in the program for the first time in the set period

Exclusion Criteria

Women invited to the program who do not agree to enter the research study by signing the informed consent
Women with breast prostheses
Women with symptoms or signs of suspected breast cancer
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note